The second wave of Corona is now engulfing children in large numbers along with the elders. Meanwhile, Bharat Biotech has now started preparing vaccines for the age group of 2-18 years. In fact, Bharat Biotech has got the approval from the Drug Controller General of India (DCGI) for the testing of phase two and three. NITI Aayog member Dr VK Paul said that its clinical trials would begin in the next 10-12 days.
Earlier, on May 11, the Covid-19 Subject Expert Committee of the Central Drugs Standard Control Organization (CDSCO) discussed the application made by Bharat Biotech, in which the safety and disease of two children in the age group of two years to 18 years of their covaxin vaccine It was requested to allow the second / third phase of the test to assess other things including increasing the immunity. At the same time, permission was also received from the Drug Controller General of India (DCGI), which cleared the way for the trial.